NCT02409784

Brief Summary

Regional brain glucose hypometabolism occurs during aging and may contribute to the onset of aging-related cognitive impairment in humans. Ketones are the main alternative energy substrate to glucose for the brain. Several studies show that brain ketone uptake and metabolism are unaltered in cognitively-normal older persons and in Alzheimer's disease (AD). Nutritional ketosis is reported to have a positive impact on cognitive performances in mild cognitive impairment and AD. Nevertheless, changes in regional brain glucose and ketone uptake in adults are poorly understood during diet-induced experimental ketosis. The investigators hypothesis was that during diet-induced ketosis, brain ketone uptake would be directly correlated with the elevation of blood ketone levels and inversely correlated to brain glucose uptake.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Mar 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 7, 2015

Completed
3 years until next milestone

Results Posted

Study results publicly available

April 6, 2018

Completed
Last Updated

February 15, 2019

Status Verified

April 1, 2015

Enrollment Period

10 months

First QC Date

March 27, 2015

Results QC Date

August 29, 2017

Last Update Submit

February 8, 2019

Conditions

Keywords

Brain metabolismKetonesKetogenic dietTEP scan

Outcome Measures

Primary Outcomes (2)

  • Mean in Cerebral Metabolic Rate of Acetoacetate Before or After 4 Days of Ketogenic Diet

    At baseline (approximatively 1 month before the onset of the diet) and right after a 4 days ketogenic diet

  • Mean in Cerebral Metabolic Rate of Glucose Before or After 4 Days of Ketogenic Diet

    At baseline (approximatively 1 month before the onset of the diet) and right after a 4 days ketogenic diet

Study Arms (1)

Ketogenic diet

EXPERIMENTAL

Pre/Post TEP study with a 4 days ketogenic diet (KD). Interventions 1: Pre-KD = Participants did a TEP before starting the 4-day diet Intervention 2: Post-KD = Participants did a TEP after completing the 4-day diet

Dietary Supplement: Pre-KDDietary Supplement: Post-KD

Interventions

Pre-KDDIETARY_SUPPLEMENT

Before starting 4 days of 4:1 (lipids:protein/carbohydrates) ketogenic diet

Ketogenic diet
Post-KDDIETARY_SUPPLEMENT

After 4 days of 4:1 (lipids:protein/carbohydrates) ketogenic diet

Ketogenic diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults
  • No signs of cognitive impairment

You may not qualify if:

  • Not within the age limits
  • Pregnancy or breast feeding
  • Incapacity to withstand a supine position for 40 min
  • Non lacunar infarction
  • Known psychiatric history of schizophrenia, psychotic disorders, major affective disorders (bipolar disorder and major depression \<5 years), panic disorder, obsessive compulsive disorders and other conditions that may affect memory
  • Epilepsy, brain trauma with loss of consciousness, subarachnoid hemorrhage
  • History of alcool and/or substances abuse (excessive alcool consumption ≥10 drinks/weeks)
  • Parkinson disease
  • Down syndrome
  • Inflammatory disease
  • Abnormal blood pressure, liver or kidney function, blood count
  • Dyslipidemia, hypothyroidism, osteoporosis
  • Presence of a metal object in the body

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ketosis

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Results Point of Contact

Title
Pr. Stephen Cunnane
Organization
Université de Sherbrooke

Study Officials

  • Stephen C Cunnane, PhD

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Ten participants received a very high fat ketogenic diet (KD) (4.5:1; lipid:protein plus carbohydrates) for four days.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2015

First Posted

April 7, 2015

Study Start

March 1, 2014

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

February 15, 2019

Results First Posted

April 6, 2018

Record last verified: 2015-04